Latest news
Loading news…
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Biohaven Pharmaceutical on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Biohaven Pharmaceutical was acquired by Pfizer in 2022 for $11.6B.
Total Funding
$1.68B
Funding Rounds
11
Last Funding
Acquisitions
2
Investments
3
1 exits
Monthly Visits
Contacts
363
Patents
25
About Biohaven Pharmaceutical
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- Active products
- 27
- Patents granted
- 25
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $8.82M
Investor Activity
- Investments
- 3
- Lead investments
- 2
- Portfolio orgs
- 2
- Exits
- 1
Company Info
- Org types
- company, investor
- HQ
- New Haven, Connecticut, United States
Signals & Scores
- Trend (7d)
- -0.2
- Trend (30d)
- 3.6
- Trend (90d)
- 5.7
Biohaven Pharmaceutical Funding Rounds
11 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 11Show
Page 1 / 3
Biohaven Pharmaceutical Investments
Loading columns…
0 of 0Show
Page 1 / 1
Biohaven Pharmaceutical Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Channel Biosciences | $100M | 2022-02-25 | Biohaven Pharmaceutical | BiopharmaBiotechnologyPharmaceutical | United States |
| Kleo | $20M | 2021-01-07 | Biohaven Pharmaceutical | Health CareMedicalPharmaceutical | United States |
1–2 of 2Show
Page 1 / 1
Biohaven Pharmaceutical Key People
Chief Executive Officer
Medical Director
Co-Founder and Strategic Advisor
Board o Directors
Chief Financial Officer
Chief Commercial Officer, Migraine and Common Diseases
Chief Financial Officer
Chief Commercial Officer
SVP, Kv7 Strategy and Development
SVP, Clinical Development & Regulatory Strategy
363
professional contacts at Biohaven Pharmaceutical
Contact execs at Biohaven Pharmaceutical →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Biohaven Pharmaceutical
People who checked this page also checked these
Sectors Biohaven Pharmaceutical invests & acquires in
Browse the full Acquirezy directory.